A metagenomic study of biliary microbiome change along the cholecystitis‐carcinoma sequence. Issue 2 (11th June 2020)

• Record Type: Journal Article
• Authors: Song, Xiaoling; Wang, Xu'an; Hu, Yunping; Li, Huaifeng; Ren, Tai; Li, Yongsheng; Liu, Liguo; Li, Lin; Li, Xuechuan; Wang, Ziyi; Huang, Wen; Bao, Runfa; Zhang, Yijian; Li, Maolan; Wang, Xuefeng; Liu, Feng; Gu, Jun; Zheng, Linhui; Wu, Wenguang; Liu, Yingbin
• Is Part Of: Clinical and translational medicine. Volume 10:Issue 2(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-06-11
• Subjects: Clinical medicine -- Periodicals; Medicine, Experimental -- Periodicals; Medical innovations -- Periodicals; Molecular biology -- Periodicals; Pathology, Molecular -- Periodicals; 616.027
• DOI: 10.1002/ctm2.97
• Languages: English
• ISSNs: 2001-1326

Abstract

Abstract: Background: Gallbladder cancer (GBC) is the most common cancer type of the biliary tract, and an association has been found between chronic calculous cholecystitis (CCC) and an increased incidence of GBC mortality. An understanding of the relationship between CCC and its carcinogenesis may enable us to prevent and cure GBC. In this study, we attempted to explore changes in the microbiome profile that take place during the transition from chronic cholecystitis mucosa to malignant lesions. Results: Seven paired human GBC and CCC samples were provided by patients who had undergone laparoscopic cholecystectomy or radical cholecystectomy. Mucosal DNA extraction and metagenomic sequencing were performed to evaluate changes in the microbiota between the two groups. We found that GBC patients and CCC patients shared similar stable and permanent dominant species and showed apparent differences in their biliary microbial composition and gene function. Peptostreptococcus stomatis and Enterococcus faecium may potentially play a role in GBC progression. In addition, the metagenomic species profiles, co‐abundance and co‐exclusion correlations, and CAZyme prevalence showed significant differences between the CCC and GBC groups. Conclusion: Our data suggested that changes in the microbiota between CCC and GBC may help deepen our understanding of the complex spectrum of different microbiotas involved in the development of GBC. Although the cohort size was small, this study has presented the first evidence of the existence of an altered biliary microbiota in GBC, which is clearly different from that in CCC patients. Abstract : 1. In the development of GBC, species richness and evenness are significantly increased compared with CCC group. 2. Abundance of NAD‐dependent protein deacetylase, deoxyribonuclease V, branched‐chain amino acid transport system permease protein and chorismate mutase were enriched in the GBC group. Archaeal S‐adenosylmethionine was enriched in the CCC group. 3. GHs, GTs, PLs and GEs were significantly higher in the CCC group, while GT77 was enriched in the GBC group.